TMO is the ticker symbol for THERMO FISHER SCIENTIFIC INC., a publicly traded Healthcare sector company listed on NYSE. 13F Pro tracks TMO with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is TMO a good stock to buy?

13F Pro's AI ranking engine scores TMO at 67.0/100, ranked #379 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for TMO is available at https://13fpro.ai/company/TMO. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source TMO data?

All THERMO FISHER SCIENTIFIC INC. fundamentals and ownership data come directly from SEC EDGAR. THERMO FISHER SCIENTIFIC INC. files with the SEC under CIK 97745. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

THERMO FISHER SCIENTIFIC INC. TMO

NYSEMega CapHealthcare

13F Pro quality score

Rank #379 of 2,925TOP 25%

Why it scores 67 Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$11.99B

Quarter to Jun 27

Net income

$1.74B

Quarter to Jun 27

Free cash flow

$1.68B

Quarter to Jun 27

Operating margin

17.4%

Quarter to Jun 27

Top Institutional Holders

as of Q2 2026

$168.92B total

BlackRock, Inc.

$15.50B+1.6%

VANGUARD CAPITAL MANAGEMENT LLC

$12.17B0.0%

$8.44B+0.6%

$7.06B+30.7%

$5.40B-0.9%

$4.31B+25.1%

GEODE CAPITAL MANAGEMENT, LLC

$4.18B-0.3%

FRANKLIN RESOURCES INC

$3.65B+6.7%

VANGUARD PORTFOLIO MANAGEMENT LLC

$3.12B+1.0%

Capital World Investors

$3.11B-6.8%

PRICE T ROWE ASSOCIATES INC /MD/

$2.57B-19.0%

NORGES BANK

$2.55B--

MASSACHUSETTS FINANCIAL SERVICES CO /MA/

$2.28B-1.6%

Capital Research Global Investors

$2.08B-6.0%

Bank of New York Mellon Corp

$1.97B+4.6%

BANK OF AMERICA CORP /DE/

$1.95B-29.6%

ROYAL BANK OF CANADA

$1.72B-12.3%

NORTHERN TRUST CORP

$1.67B-2.5%

Capital International Investors

$1.60B-18.2%

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

$1.56B+6.1%

DODGE & COX

$1.53BNew

GOLDMAN SACHS GROUP INC

$1.48B-6.3%

Fisher Asset Management, LLC

$1.46B+2.2%

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt

$1.38B-5.4%

Grantham, Mayo, Van Otterloo & Co. LLC

$1.37B+9.5%

See all 2,635 institutional holders →

What's Driving TMO's Business? Latest 10-Q Breakdown

31/31 datapoints verified

AI-extracted from the 10-Q filed 2026-07-31 — Q2 FY2026 (quarter ended June 27, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Q2 revenue rose 10% to $11.99B, but only 5% organically — acquisitions (chiefly Clario) contributed 5 points — while GAAP operating margin improved to 17.4% from 16.9%.

Biggest Revenue Drivers

Laboratory Products and Biopharma Services$6,652M+12% YoY

Growth in the research and safety market channel and the clinical research business

Life Sciences Solutions$2,355M+13% YoY

Bioproduction grew $196 million on higher pharma and biotech demand plus the 2025 filtration and separation acquisition

Biggest Revenue Drivers

Total revenue: $11,994M+10% YoY

Laboratory Products and Biopharma Services$6,652M+12% YoY

Growth in the research and safety market channel and the clinical research business

Within Laboratory Products and Biopharma Services

Clinical research$2,396M

Grew $441 million, contributing 7 points of segment reported growth, primarily driven by the impact of the Clario acquisition

Life Sciences Solutions$2,355M+13% YoY

Bioproduction grew $196 million on higher pharma and biotech demand plus the 2025 filtration and separation acquisition

Analytical Instruments$1,799M+7% YoY

Growth across all three businesses, led by electron microscopy (+$55 million)

Specialty Diagnostics$1,188M+6% YoY

Driven by the healthcare market channel (+$36 million) and immunodiagnostics business

Largest Expense Items

Cost of service revenues$3,650M

Rose from $3,207M a year ago as service revenues grew to $5,171M

Cost of product revenues$3,462M

Up from $3,239M; company cites productivity improvements from its PPI Business System

Selling, general and administrative expenses$2,333M

Up from $2,140M, reflecting acquisitions and strategic investments in commercial capabilities

Research and development expenses$364M

Up modestly from $352M

Margins: GAAP operating margin rose 0.5 pt to 17.4% and adjusted margin 0.9 pt to 22.8%, due primarily to strong productivity improvements, offset in part by unfavorable business mix.

Watch Items from the Filing

Reported growth of 10% included 5 points from acquisitions and 1 point currency; organic growth was only 5%.
Clario purchase price totaled $9.10B, adding $5,934M goodwill; cash fell from $9.85B to $4.06B and total debt rose to $42.55B.
Net interest expense nearly doubled to $194M from $107M on higher debt for buybacks, dividends and the Clario acquisition.
Additional restructuring charges of approximately $220 million expected, primarily in the Laboratory Products and Biopharma Services segment.
Remaining performance obligations of $29.70 billion, about 52% expected to be recognized within the next twelve months.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Debt/Equity

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TMO

Earnings Per Share

13fpro.ai/company/TMO

Loading ratio trend…

THERMO FISHER SCIENTIFIC INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$44.6B	$6.7B	17.4%
FY 2024	10-K	$42.9B	$6.3B	17.1%
FY 2023	10-K	$42.9B	$6.0B	16.0%
FY 2022	10-K	$44.9B	$7.0B	18.7%
FY 2021	10-K	$39.2B	$7.7B	25.6%
FY 2020	10-K	$32.2B	$6.4B	24.2%

About THERMO FISHER SCIENTIFIC INC. (TMO): stock profile, AI score and financials

THERMO FISHER SCIENTIFIC INC. (TMO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TMO at 67.0/100 on a composite quality score built from its SEC filings, placing it at rank #379 of 2,925 stocks — the top 25% of the AI-ranked universe. TMO scores in the top quartile across revenue scale (96.6), balance sheet strength (75.5). Based on the latest XBRL financial filings (Q2 2026), THERMO FISHER SCIENTIFIC INC. reports quarterly revenue of $12.0B, net income of $1.7B, an operating margin of 17.4%. Top institutional holders of TMO by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. TMO trades on the NYSE exchange and files with the SEC under CIK 97745. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TMO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for THERMO FISHER SCIENTIFIC INC. directly from SEC EDGAR.

Financials through the period ended Jun 27, 2026SEC EDGAR: CIK 97745 →

THERMO FISHER SCIENTIFIC INC. TMO

Top Institutional Holders

What's Driving TMO's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Biggest Revenue Drivers

Largest Expense Items

Watch Items from the Filing

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

TMO key financials by period

TMO insiders

Congress trading in TMO

About THERMO FISHER SCIENTIFIC INC. (TMO): stock profile, AI score and financials

THERMO FISHER SCIENTIFIC INC. TMO

Top Institutional Holders

What's Driving TMO's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

TMO key financials by period

Companies similar to TMO

TMO insiders

Congress trading in TMO

About THERMO FISHER SCIENTIFIC INC. (TMO): stock profile, AI score and financials